Bristol Glucophage Petition Seeks FDA Hearing Before ANDA Approval

FDA should conduct a public proceeding to determine appropriate labeling for generic metformin before approving ANDAs for versions of Bristol-Myers Squibb's Glucophage, the company argues in a citizen petition submitted to FDA Dec. 26